• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Enforcement Report - Week of September 25, 2013

  • Print
  • Share
  • E-mail

Product Detail

Product Description Bevacizumab (Avastin) 2.5mg/0.1mL PF Inj., 0.1 mL syringe, Compounded by Leiter's Compounding Pharmacy, 1700 Park Ave., # 30, San Jose, CA 95126
Recall Number D-1040-2013
Classification Class II
Code Info Lot #: 08052013@1, 08052013@4, Exp 11/03/2013
Product Distributed Qty 265 vials
Reason For Recall Lack of Assurance of Sterility: Leiter Pharmacy is recalling due bacterial contamination found after investigation at contract testing laboratory discovered that OOS/failed results were reported to customers as passing. Hence the sterility of the products cannot be assured.

Event Detail

Event Id 66103
Product Type Drugs
Status Ongoing
Recalling Firm Leiter's Pharmacy
City San Jose
State CA
Country US
Voluntary / Mandated Voluntary: Firm Initiated
Recall Initiation Date 2013-08-26
Initial Firm Notification of Consignee or Public Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Distribution Pattern Nationwide